Showing results (1-10 of 754) with videos related to

Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|November 21, 2021
Effect of prophylactic endoscopic clip placement on clinically significant post-endoscopic mucosal resection bleeding in the right colon: a single-centre, randomised controlled trialSunil Gupta, Mayenaaz Sidhu, Neal Shahidi, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2021
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 studySeverine Vermeire, Peter L Lakatos, Timothy Ritter, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2021
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 studySilvio Danese, Jean-Frederic Colombel, Milan Lukas, et al.
The Lancet. Gastroenterology & Hepatology|March 13, 2021
Predicting endoscopic activity recovery in England after COVID-19: a national analysisKai Man Alexander Ho, Amitava Banerjee, Mark Lawler, et al.
The Lancet. Gastroenterology & Hepatology|March 19, 2021
Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trialChristina J Sperna Weiland, Xavier J N M Smeets, Wietske Kievit, et al.
The Lancet. Gastroenterology & Hepatology|November 25, 2021
Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based studyEmilie C H Breekveldt, Iris Lansdorp-Vogelaar, Esther Toes-Zoutendijk, et al.
The Lancet. Gastroenterology & Hepatology|April 8, 2019
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trialPhilippe Merle, Jean-Frederic Blanc, Jean-Marc Phelip, et al.
The Lancet. Gastroenterology & Hepatology|January 17, 2021
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based studyEva J A Morris, Raphael Goldacre, Enti Spata, et al.
The Lancet. Gastroenterology & Hepatology|January 18, 2021
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysisDavid Petroff, Valentin Blank, Philip N Newsome, et al.
The Lancet. Gastroenterology & Hepatology|January 13, 2022
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trialSunil S Solomon, Sandra Wagner-Cardoso, Laura Smeaton, et al.
Pageof 76